Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.2950
-0.0270
(-2.04%)
At close: April 4 at 5:29:52 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-162,752
-162,752
-286,663
-358,915
-346,445
Investing Cash Flow
55,000
55,000
182,095
67,880
-102,429
Financing Cash Flow
-1,066
-1,066
54,681
223,934
--
End Cash Position
33,036
33,036
139,747
189,573
247,322
Capital Expenditure
--
--
--
-7,089
-383
Issuance of Capital Stock
--
--
59,281
250,482
--
Free Cash Flow
-162,752
-162,752
-286,663
-366,004
-346,828
12/31/2021 - 3/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HNSA.ST Hansa Biopharma AB (publ)
21.70
-4.15%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1800
-4.66%
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1264
+6.94%
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
ATORX.ST Alligator Bioscience AB (publ)
0.0055
-9.84%
QUIA.ST Quia Pharma AB (publ)
0.0094
+62.07%
IMMU.ST Mendus AB (publ)
5.70
+2.46%
BIOSGN.ST Biosergen AB
0.3450
+4.23%
KAN.ST Kancera AB (publ)
1.1020
-1.61%